Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2011

01-08-2011 | Case Report

Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms

Authors: Mizuho Nara, Atsushi Komatsuda, Masumi Fujishima, Naohito Fujishima, Miho Nara, Takako Iino, Hiroshi Ito, Ken-ichi Sawada, Hideki Wakui

Published in: Clinical and Experimental Nephrology | Issue 4/2011

Login to get access

Abstract

A 22-year-old woman, who often carried heavy books, was admitted for evaluation of hyperreninemic hypertension. Two months prior to admission, she noted leg edema. Radiological examinations revealed bilateral renal infarction with no other abnormal findings. An echocardiography showed a patent foramen ovale (PFO). Hypertension was considered secondary to renal infarction caused by paradoxical embolism through PFO. Antihypertensive and anticoagulant therapy led to improvement of hypertension. In previously reported cases of renal paradoxical embolism, multiorgan involvement was usually observed. Our case is unique in that embolism was confirmed only in the kidneys, and that clinical characteristics of renal embolism were not observed.
Literature
1.
go back to reference Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108:549–58.CrossRefPubMed Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108:549–58.CrossRefPubMed
2.
go back to reference Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, et al. Patent foramen ovale in cryptogenic stroke. Arch Intern Med. 2004;164:950–6.CrossRefPubMed Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, et al. Patent foramen ovale in cryptogenic stroke. Arch Intern Med. 2004;164:950–6.CrossRefPubMed
3.
go back to reference Bartz PJ, Cetta F, Cabalka AK, Reeder GS, Squarcia U, Agnetti A, et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc. 2006;81:615–8.CrossRefPubMed Bartz PJ, Cetta F, Cabalka AK, Reeder GS, Squarcia U, Agnetti A, et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc. 2006;81:615–8.CrossRefPubMed
4.
go back to reference Iwasaki M, Joki N, Tanaka Y, Hara H, Suzuki M, Hase H. A suspected case of paradoxical renal embolism through the patent foramen ovale. Clin Exp Nephrol. 2011;15:147–50.CrossRefPubMed Iwasaki M, Joki N, Tanaka Y, Hara H, Suzuki M, Hase H. A suspected case of paradoxical renal embolism through the patent foramen ovale. Clin Exp Nephrol. 2011;15:147–50.CrossRefPubMed
5.
go back to reference Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis. 1994;24:130–41.CrossRefPubMed Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis. 1994;24:130–41.CrossRefPubMed
6.
go back to reference Hudgens SA, Cella D, Caprini CA, Caprini JA. Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes. 2003;1:76.CrossRefPubMedPubMedCentral Hudgens SA, Cella D, Caprini CA, Caprini JA. Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes. 2003;1:76.CrossRefPubMedPubMedCentral
7.
go back to reference Bolderman R, Oyen R, Verrijcken A, Knockaert D, Vanderschueren S. Idiopathic renal infarction. Am J Med. 2006;119:356.e9–12.CrossRefPubMed Bolderman R, Oyen R, Verrijcken A, Knockaert D, Vanderschueren S. Idiopathic renal infarction. Am J Med. 2006;119:356.e9–12.CrossRefPubMed
8.
go back to reference Paris B, Bobrie G, Rossignol P, Le Coz S, Chedid A, Plouin PF. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens. 2006;24:1649–54.CrossRefPubMed Paris B, Bobrie G, Rossignol P, Le Coz S, Chedid A, Plouin PF. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens. 2006;24:1649–54.CrossRefPubMed
Metadata
Title
Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms
Authors
Mizuho Nara
Atsushi Komatsuda
Masumi Fujishima
Naohito Fujishima
Miho Nara
Takako Iino
Hiroshi Ito
Ken-ichi Sawada
Hideki Wakui
Publication date
01-08-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0436-y

Other articles of this Issue 4/2011

Clinical and Experimental Nephrology 4/2011 Go to the issue

Editorial Announcement

A new journal: CEN Case Reports

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine